Abvc Biopharma, Inc.
ABVC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001173313
No open-market purchases or sales by Abvc Biopharma, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.72M in total; no superinvestor holds it.
Other share classesECOC
Q4 2024 vs. Q3 2024
How the institutions holding Abvc Biopharma, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 9 | 13 | +4 |
| Shares | 228.1K | 409.2K | +181.1K (+79.4%) |
| Value | $155.9K | $241.0K | +$85.2K (+54.7%) |
New holders (4)
Institutions that held Abvc Biopharma, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 40,743 | $24.0K | 0.00% |
| Virtu Financial LLC | 15,935 | $9.00K | 0.00% |
| SBI Securities Co., Ltd. | 662 | $391 | 0.00% |
| UBS Group AG | 10 | $6 | 0.00% |
Sold out (0)
Institutions that held Abvc Biopharma, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
None.